Resveratrol inhibits angiotensin II-induced ERK1/2 activation by downregulating quinone reductase 2 in rat vascular smooth muscle cells

Grüntzig, 1979, Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty, N Engl J Med, 301, 61, 10.1056/NEJM197907123010201 Kobayashi, 2008, Current status of coronary artery bypass grafting, Gen Thorac Cardiovasc Surg, 56, 260, 10.1007/s11748-008-0251-x Brophy, 2003, Evidence for use of coronary stents: A hierarchical bayesian meta-analysis, Ann Intern Med, 138, 777, 10.7326/0003-4819-138-10-200305200-00005 Simons, 1992, Antisense cmyb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo, Nature, 359, 67, 10.1038/359067a0 Bennett, 2001, Mechanisms Implications for design of rational therapy of angioplasty and stent restenosis, Pharmacol Ther, 91, 149, 10.1016/S0163-7258(01)00153-X Hao, 2003, Arterial smooth muscle cell heterogeneity: implications for atherosclerosis and restenosis development, Arterioscler Thromb Vasc Biol, 23, 1510, 10.1161/01.ATV.0000090130.85752.ED Ekshyyan, 2007, Resveratrol inhibits rat aortic vascular smooth muscle cell proliferation via estrogen receptor dependent nitric oxide production, J Cardiovasc Pharmacol, 50, 83, 10.1097/FJC.0b013e318059ae80 Wang, 2004, Identification and purification of resveratrol targeting proteins using immobilized resveratrol affinity chromatography, Biochem Biophys Res Commun, 323, 743, 10.1016/j.bbrc.2004.08.174 Buryanovskyy, 2004, Crystal structure of quinone reductase 2 in complex with resveratrol, Biochemistry, 43, 11417, 10.1021/bi049162o Cai, 2008, Negative regulation of quinone reductase 2 by resveratrol in cultured vascular smooth muscle cells, Clin Exp Pharmacol Physiol, 35, 1419 Zhang, 2008, Effects of isorhynchophylline on angiotensin II-induced proliferation in rat vascular smooth muscle cells, J Pharm Pharmacol, 60, 1673, 10.1211/jpp.60.12.0014 Kuma, 2007, Angiotensin II-induced growth of vascular smooth muscle cells is associated with modulation of cell surface area and platelet-derived growth factor receptor expression, Clin Exp Pharmacol Physiol, 34, 153, 10.1111/j.1440-1681.2007.04535.x Griendling, 2000, NAD(P)H oxidase: role in cardiovascular biology and disease, Circ Res, 86, 494, 10.1161/01.RES.86.5.494 Sano, 2001, ERK and p38 MAPK, but not NFkappaB, are critically involved in reactive oxygen species-mediated induction of IL-6 by angiotensin II in cardiac fibroblasts, Circ Res, 89, 661, 10.1161/hh2001.098873 Shih, 2001, Reactive oxygen species modulate angiotensin II-induced beta-myosin heavy chain gene expression via Ras/Raf/extracellular signal-regulated kinase pathway in neonatal rat cardiomyocytes, Biochem Biophys Res Commun, 283, 143, 10.1006/bbrc.2001.4744 Haider, 2002, Resveratrol suppresses angiotensin II-induced Akt/protein kinase B and p70 S6 kinase phosphorylation and subsequent hypertrophy in rat aortic smooth muscle cells, Mol Pharmacol, 62, 772, 10.1124/mol.62.4.772 Chao, 2005, Resveratrol inhibits angiotensin II-induced endothelin-1 gene expression and subsequent proliferation in rat aortic smooth muscle cells, Eur J Pharmacol, 515, 1, 10.1016/j.ejphar.2005.03.035 Gresele, 2008, Resveratrol, at concentrations attainable with moderate wine consumption, stimulates human platelet nitric oxide production, J Nutr, 138, 1602, 10.1093/jn/138.9.1602 Hsieh, 2007, Resveratrol attenuates ischemia-reperfusion-induced leukocyte-endothelial cell adhesive interactions and prolongs allograft survival across the MHC barrier, Circ J, 71, 423, 10.1253/circj.71.423 Li, 2006, Upregulation of endogenous antioxidants and phase 2 enzymes by the red wine polyphenol, resveratrol in cultured aortic smooth muscle cells leads to cytoprotection against oxidative and electrophilic stress, Pharmacol Res, 53, 6, 10.1016/j.phrs.2005.08.002 Griendling, 2003, Oxidative stress and cardiovascular injury part I: basic mechanisms and in vivo monitoring of ROS, Circulation, 108, 1912, 10.1161/01.CIR.0000093660.86242.BB Zalba, 2000, Vascular oxidant stress: molecular mechanisms and pathophysiological implications, J Physiol Biochem, 56, 57, 10.1007/BF03179777 Deshpande, 2002, Mechanism of hydrogen peroxide–induced cell cycle arrest in vascular smooth muscle, Antioxid Redox Signal, 4, 845, 10.1089/152308602760599007 Gong, 2008, Quinone oxidoreductases and vitamin K metabolism, Vitam Horm, 78, 85, 10.1016/S0083-6729(07)00005-2 Hsieh, 2008, Identification of glutathione sulfotransferase-pi (GSTP1) as a new resveratrol targeting protein(RTP) and studies of resveratrol-responsive protein changes by resveratrol affinity chromatography, Anticancer Res, 28, 29 Yoo, 2010, Inhibitory effects of cilostazol on proliferation of vascular smooth muscle cells (VSMCs) through suppression of the ERK1/2 pathway, J Atheroscler Thromb, 17, 1009, 10.5551/jat.4309 Lee, 2009, Inhibition of proliferation and migration by piceatannol in vascular smooth muscle cells, Toxicol In Vitro, 23, 1284, 10.1016/j.tiv.2009.07.023 Won, 2006, Catechins inhibit angiotensin II-induced vascular smooth muscle cell proliferation via mitogen-activated protein kinase pathway, Exp Mol Med, 38, 525, 10.1038/emm.2006.62 El-Mowafy, 2009, Resveratrol reverses ET-1-evoked mitogenic effects in human coronary arterial cells by activating the kinase-G to inhibit ERK-enzymes, Int J Cardiol, 136, 263, 10.1016/j.ijcard.2008.04.094 Eguchi, 1996, J Biol Chem, 271, 14169, 10.1074/jbc.271.24.14169 Ahn, 2007, Deficiency of NRH: quinone oxidoreductase 2 differentially regulates TNF signaling in keratinocytes: up-regulation of apoptosis correlates with downregulation of cell survival kinases, Cancer Res, 67, 10004, 10.1158/0008-5472.CAN-07-2213